DK
Therapeutic Areas
Propanc Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRP | Advanced Solid Tumors (Pancreatic, Ovarian) | Phase 1/2 |
Leadership Team at Propanc Biopharma
JN
James Nathanielsz
Chief Executive Officer, Managing Director
SD
Steven D. Neill
Former Chief Financial Officer
DJ
Dr. Julian Kenyon
Former Chief Scientific Officer
BB
Belinda Bales
Former Company Secretary
RS
Roland Scollay
Former Board Member
PC
Paul C. H. Lee
Former Board Member